On any given night, you can find them by scrolling through Instagram or TikTok: brief videos featuring a vial held up to the camera, a confident voice, and ring-light glow. Someone explaining their peptide “stack.” This person is frequently young, attractive, and has hundreds of thousands of followers. BPC-157 for the wound that never fully recovered. CJC-1295 for fat loss and sleep. GHK-Cu for hair and skin. The framing is informal, enthusiastic, and largely unaffected by the fact that the majority of what is being described has not been authorized for human use by any regulatory body worldwide.
In 2026, wellness culture has reached this point. Through celebrity endorsements, podcast mentions, and the unique alchemy of social media that transforms unverified personal testimonials into perceived consensus, peptides—short chains of amino acids that occur naturally in the body and perform real biological functions—have moved from the obscure corners of bodybuilding forums into something approaching a mainstream health movement. The term “glow-up potion” was not created by journalists. In reality, that’s what people on the internet are referring to them as.
The list of well-known figures associated with peptide enthusiasm is truly impressive. Peptide shots are one of Gwyneth Paltrow’s most important wellness tools. Joe Rogan attributed the recovery of a chronic injury to BPC-157. They have been extensively covered by Andrew Huberman on his podcast. Furthermore, Robert F. Kennedy Jr. has made a public pledge to stop the FDA’s “aggressive suppression” of peptide therapies. Kennedy is currently the U.S. Secretary of Health and Human Services, a position with significant regulatory authority. It’s worth pausing on that final section. The situation is made much more complicated by the fact that the country’s top health official is, at least rhetorically, on the gray market side of this argument.
| Topic | Injectable Peptides Trend — Viral Wellness, Unapproved Use, and Expert Warnings |
|---|---|
| What Are Peptides? | Short chains of amino acids; naturally occur in the body; play roles in immune function and hormone production |
| Popular Unapproved Peptides | BPC-157, TB-500, CJC-1295, GHK-Cu, Tesamorelin (off-label), Sermorelin, NAD+ |
| Primary Source for Gray Market Supply | Online vendors, many shipping from China; often labeled “for research use only” |
| FDA Status | Not approved for general human use; FDA restricted compounding pharmacies from producing many popular peptides in 2023 |
| Notable Proponents | Jennifer Aniston, Gwyneth Paltrow, Joe Rogan, Andrew Huberman, Dr. Mark Hyman, RFK Jr. |
| Key Risk: Mislabeling | BTLabs testing found 20%+ of unapproved peptides mislabeled since October; concentration rarely matches label |
| Known Adverse Effects Reported | Migraines, nausea, depression, anhedonia, blood in urine; two women hospitalized at anti-aging conference |
| Expert Warning | Dr. Eric Topol (Scripps Research): “There isn’t any meaningful data on these peptides. People are taking them on blind faith.” |
| Researcher Perspective | Luke Turnock, University of Lincoln: Peptides rapidly moving from niche bodybuilder use to mainstream wellness |
| Reference Links | TIME Magazine – Anti-Aging Peptide Shots Trending on Social Media / The Guardian – Injectable Peptides Touted as Glow-Up Potion |
In reality, the science tells a different tale. Cardiologist and director of the Scripps Research Translational Institute Dr. Eric Topol has been direct about it: the majority of these unapproved peptides have no significant clinical evidence to support their use in humans. For substances like BPC-157, there are few animal studies available; enough to imply biological activity but insufficient to determine human safety or dosage. The advantages that people report on the internet seem genuine to them, but the placebo effect is strong, and the lack of controlled trials makes it impossible to distinguish between actual pharmacological effects and belief. In a paper published in late 2025, Chris Mendias, a rehabilitation clinician-scientist in Phoenix whose patients have been inquiring about peptides more frequently, concluded that clinical trials are desperately needed to close the gap between online myths and real science. He pointed out that the paper had not yet undergone official peer review.
On its own, the supply chain for these goods is a major issue. The majority of unapproved peptides that are sold online originate from Chinese suppliers and are frequently marked “for research purposes only, not for human consumption.” This labeling is a legal workaround that lets vendors move goods while shifting all responsibility to the customer. More than 20% of unapproved peptide samples tested since October had incorrect labels, according to testing done by drug testing company BTLabs. One compound may be listed on the vial, but the contents may be completely different. Most of the time, the concentration on the label did not correspond to the actual content. Individuals who order syringes from Amazon, watch YouTube tutorials on injection technique, and inject drugs they bought from unreliable websites are doing so with virtually no knowledge of the contents of the products they are using.
In certain instances, the repercussions have been dire. Two women who received peptide injections at a booth run by a doctor who specialized in what was being marketed as “age reversal” therapies were hospitalized in critical condition at an anti-aging conference last year. Social media users report a variety of negative side effects from self-experimentation, including migraines, nausea, depression, anhedonia, and at least one instance where a patient started urinating blood after taking BPC-157, according to Mendias. These are not uncommon drug interactions that were identified during a clinical trial. These are individuals who inject unproven substances on the advice of a podcast, only to discover later that something went wrong.
The unapproved peptide market actually grew, which is an odd irony. Citing inadequate safety data, the FDA prohibited compounding pharmacies, which are subject to state regulation and some FDA oversight, from manufacturing many of the well-known peptides in 2023. Reducing risk was the goal. Jordan Glenn of SuppCo, a supplement tracking app with more than 640,000 users, claims that the result was to completely drive demand underground. At least the product was coming from a facility that was subject to inspection prior to the crackdown. It came from a gray market with virtually no accountability after that. Glenn stated, “We moved from a safer model to a ‘trust me, bro’ kind of situation,” pointing out that almost 90% of SuppCo users surveyed said they would be interested in using the app to track peptides.
It’s difficult to ignore the similarities between this whole situation—the unsubstantiated claims, the celebrity amplification, the gray market supply chains, and the regulatory void—and other wellness trends that burn brightly and actually hurt some people. This time, the difference is that instead of ingesting these drugs, people are injecting them. Compared to a supplement capsule, the margin for error with an injectable compound—which could be contaminated, mislabeled, or just incorrect for a specific person’s biology—is much smaller. To put it simply, just because a friend or influential person believes something, it doesn’t mean there is scientific evidence to back it up. That warning is not brand-new. However, given the direction this trend is taking, it might need to be stated more frequently and loudly.
